NCT04236635 - Histopathology Following CCH Injection | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

December 20, 2019

Primary Completion Date

September 23, 2020

Study Completion Date

October 26, 2020

Conditions

Characteristics of Subcutaneous Tissue

Interventions

DRUG

Collagenase Clostridium Histolyticum Single Injection Technique

CCH was injected subcutaneously using a single injection technique. Dose per each administration was 0.07 mg.

DRUG

Collagenase Clostridium Histolyticum Multiple Injection Technique

CCH was injected subcutaneously using a multiple injection technique. Dose per each administration was 0.0653 mg.

Trial Locations (2)

Endo Clinical Trial Site #2, New York

Endo Clinical Trial Site #1, Montclair